State of New Jersey Common Pension Fund D’s Adaptimmune Therapeutics ADAP Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio ADAP Stock Details ADAP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-54,718	Closed	-$7.11K	–	1474
2025 Q3	$7.11K	Hold	54,718	–	–	﹤0.01%	1460
2025 Q2	$13.1K	Hold	54,718	–	–	﹤0.01%	1473
2025 Q1	$10.8K	Buy	+54,718	New	+$28.3K	﹤0.01%	1499
2019 Q2	–	Sell	-24,000	Closed	-$103K	–	921
2019 Q1	$103K	Hold	24,000	–	–	﹤0.01%	901
2018 Q4	$138K	Hold	24,000	–	–	﹤0.01%	905
2018 Q3	$325K	Hold	24,000	–	–	﹤0.01%	902
2018 Q2	$285K	Hold	24,000	–	–	﹤0.01%	927
2018 Q1	$270K	Hold	24,000	–	–	﹤0.01%	922
2017 Q4	$160K	Hold	24,000	–	–	﹤0.01%	919
2017 Q3	$197K	Hold	24,000	–	–	﹤0.01%	927
2017 Q2	$108K	Hold	24,000	–	–	﹤0.01%	928
2017 Q1	$132K	Hold	24,000	–	–	﹤0.01%	924
2016 Q4	$97K	Hold	24,000	–	–	﹤0.01%	926
2016 Q3	$169K	Hold	24,000	–	–	﹤0.01%	915
2016 Q2	$196K	Hold	24,000	–	–	﹤0.01%	922
2016 Q1	$195K	Hold	24,000	–	–	﹤0.01%	931
2015 Q4	$289K	Hold	24,000	–	–	﹤0.01%	941
2015 Q3	$287K	Hold	24,000	–	–	﹤0.01%	930
2015 Q2	$440K	Buy	+24,000	New	+$412K	﹤0.01%	898

Other funds holding ADAP

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Empirical Finance Havertown, Pennsylvania $2.13B AUM 29.56% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State of New Jersey Common Pension Fund D's ADAP Position: Q4 2025 in Review

State of New Jersey Common Pension Fund D sold out of Adaptimmune Therapeutics (ADAP) in Q4 2025, closing a stake of 54,718 shares — an estimated $7.11K sold.

State of New Jersey Common Pension Fund D first reported a position in ADAP in Q2 2015 and held it in 19 quarters. The position peaked at $440K in Q2 2015. 10 funds tracked by Wall St. Rank hold ADAP as of Q4 2025.

State of New Jersey Common Pension Fund D reported no remaining Adaptimmune Therapeutics position as of Q4 2025 after selling out during the quarter.
State of New Jersey Common Pension Fund D sold 54,718 Adaptimmune Therapeutics shares in Q4 2025, an estimated $7.11K.
State of New Jersey Common Pension Fund D first reported a position in Adaptimmune Therapeutics in Q2 2015 and held it in 19 quarters.
State of New Jersey Common Pension Fund D's Adaptimmune Therapeutics position peaked at $440K in Q2 2015.
10 funds tracked by Wall St. Rank held Adaptimmune Therapeutics as of Q4 2025.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q4 2025, filed 30 Jan 2026.